← Back to patent-cliff list
NN-9505
Tier C — Watch / tradeNN-9505
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Obesity
Regional status
US
Phase II
2024-03-01
EU
Phase II
2024-03-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of NN-9505?
Approved indications include: Obesity.
When does the NN-9505 patent expire?
No public expiry year is available for NN-9505 yet; this page updates once verified.
How do I get a quote for NN-9505 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01